Ventrus Biosciences Inc. (VTUS) was a big mover last session with shares rising nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up over 27% in the past one-month time frame.
This specialty pharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t remained in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Ventrus Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the Med-Drug industry include Lannett Company, Inc. (LCI), WuXi PharmaTech (Cayman) Inc. (WX) and Questcor Pharmaceuticals, Inc. (QCOR). While Lannett Company sports a Zacks Rank #1 (Strong Buy), WuXi and Questcor carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment